Fibroblast-specific common fragile sites induced by aphidicolin.
The distribution and frequency of aphidicolin-induced common fragile sites were studied in chromosomes of cultured skin fibroblasts and PHA-stimulated lymphocytes from five normal individuals; 0.2 microM aphidicolin was added for the last 26 h of culture. Skin fibroblasts from five fra(X)-positive patients were also studied in the same manner. Fragile sites most frequently found in fibroblasts from normal individuals were 3q26.2, 7q11.23, 16q23, 1p31, 10q11.2, 12q23 and 7q31, whereas those in lymphocytes from the same individuals were 3p14, 16q23, Xp22, 7q32 and 14q24. The distribution of fragile sites in fibroblasts from fra(X)-positive patients was essentially identical with that in normal individuals. The average number of gaps and breaks in 100 metaphases was 36.8 in fibroblasts from normal individuals, 113.8 in those from fra(X)-positive patients, and 279 in lymphocytes from normal individuals. Their rates of chromosome-type breaks and gaps were 7.9%, 29.7% and 54.5%, respectively. Thus, the distribution and frequency of aphidicolin-induced fragile sites were different between skin fibroblasts and lymphocytes, possibly reflecting differences in their DNA replication sequence or gene activity.
Murano
I
I
Department of Pediatrics, Yamaguchi University School of Medicine, Japan.
Kuwano
A
A
Kajii
T
T
D000328:Adult; D016590:Aphidicolin; D002478:Cells, Cultured; D002648:Child; D043283:Chromosome Fragile Sites; D002873:Chromosome Fragility; D002877:Chromosomes, Human / Q000187:drug effects* / Q000648:ultrastructure; D004224:Diterpenes / Q000494:pharmacology*; D005260:Female; D005347:Fibroblasts / Q000648:ultrastructure*; D005600:Fragile X Syndrome / Q000235:genetics / Q000473:pathology*; D006801:Humans; D007223:Infant; D008214:Lymphocytes / Q000648:ultrastructure; D008297:Male; D009928:Organ Specificity; D012729:Sex Chromosome Aberrations / Q000473:pathology*; D012867:Skin
D004224:Diterpenes; D016590:Aphidicolin